$20.57
0[0.00%]
At close: Apr 26
$20.57
0[0.00%]
PreMarket: 4:20PM EDT
Latest News for Artivion Stock (NYSE:AORT)
Artivion Stock (NYSE: AORT)
Categories: All
Monday, April 08, 2024
Monday, February 19, 2024
Friday, February 16, 2024
- Why DoorDash Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Feb 16, 2024, 1:04PM
- Applied Materials Posts Upbeat Earnings, Joins Texas Roadhouse, Vulcan Materials And Other Big Stocks Moving Higher On FridayAvi Kapoor - Feb 16, 2024, 10:09AM
- Artivion shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY24 revenue guidance. Also, Needham maintained a Buy rating on the stock and raised its price target from $22 to $25.Benzinga Newsdesk - Feb 16, 2024, 9:30AM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Feb 16, 2024, 8:06AM
- Needham Maintains Buy on Artivion, Raises Price Target to $25Benzinga Newsdesk - Feb 16, 2024, 5:44AM
Thursday, February 15, 2024
Wednesday, February 14, 2024
Monday, January 29, 2024
Thursday, December 28, 2023
Thursday, December 07, 2023
Wednesday, December 06, 2023
Tuesday, November 28, 2023
Tuesday, November 21, 2023
- Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Nov 21, 2023, 1:28PM
- Agilent Posts Upbeat Results, Joins Burlington Stores, Hibbett And Other Big Stocks Moving Higher On TuesdayLisa Levin - Nov 21, 2023, 11:42AM
- A Congress Member Bought Up To $200K In Artivion Stock: Here's What You Need To KnowBenzinga Insights - Nov 21, 2023, 10:05AM
- Why Symbotic Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving PremarketLisa Levin - Nov 21, 2023, 8:05AM
Friday, November 03, 2023
Thursday, November 02, 2023
Thursday, October 05, 2023
- Artivion Announces Presentation Of Real World Data From Post Market Study Of On-X Aortic Heart Valve Replacement Patients Treated With Low Dose WarfarinBenzinga Newsdesk - Oct 5, 2023, 4:53PM
- Artivion Announces Presentation Of Interim Data From AMDS PERSEVERE Trial At 37th European Association For Cardio-Thoracic Surgery Annual MeetingBenzinga Newsdesk - Oct 5, 2023, 4:10PM
Thursday, August 24, 2023
Thursday, August 10, 2023
Friday, August 04, 2023
Thursday, August 03, 2023
- Artivion Raises FY23 Revenues Forecast From $337M-$348M To $342M-$350M, Consensus $340.69MBenzinga Newsdesk - Aug 3, 2023, 5:56PM
- Artivion Q2 Adj EPS $0.06 Beats $(0.08) Estimate, Sales $89.25M Beat $84.24M EstimateBenzinga Newsdesk - Aug 3, 2023, 4:46PM
- Earnings Scheduled For August 3, 2023Benzinga Insights - Aug 3, 2023, 6:59AM
Wednesday, August 02, 2023
Tuesday, May 23, 2023
Monday, May 08, 2023
Friday, May 05, 2023
- Artivion shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. Also, Needham maintained a Buy rating on the stock and raised its price target from $23 to $26.Benzinga Newsdesk - May 5, 2023, 11:17AM
- Needham Maintains Buy on Artivion, Raises Price Target to $26Benzinga Newsdesk - May 5, 2023, 5:13AM